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Healthcare has experienced a deep transformation characterized by significant growth in expenditures 
during the twentieth century. Today, it represents one of the fastest growing sectors of the economy.1 
While estimates of health expenditures came out to about 1% of a country’s total GDP in 1900, OECD 
statistics put that proportion at 4–6% in 1970 (5.2% in France; 5.7% in Germany; 4.4% in Japan; 4% in 
the UK; and 6.2% in the US) and on a steady increase through the present day. In 2015, health 
expenditures accounted for 11% of the GDP in France, 11.1% in Germany, 11.2% in Japan, 9.8% in the 
UK, and 16.9% in the US.2 Moreover, this phenomenon is not limited to developed countries. Emerging 
countries follow the same trend, too, with health expenditures that went from 4% to 6% of GDP in 
China and 4% to 5% in India between 1995 and 2014, for example.3 Throughout the world, endless 
growth of health expenditures has led to financial concerns for governments of all kinds. Scholars have 
also engaged in public debate, trying to provide evidence to explain this development. The 
mechanisms of the growth of health expenditures led to the emergence of a new academic field in the 
1960s—health economics, whose main objectives are to evaluate the most economically efficient 
system to take care of people’s health and to measure the impact of new technologies on health 
expenditures.4  
Health industries stand as one of the cornerstones of the welfare system, and the regulation of market 
access to the corresponding products and services represents a major battlefield in political debates in 
OECD countries. In referring to “health industries,” we consider the various activities in manufacturing 
(drugs, biotechnology, medical devices, etc.), infrastructure (hospital design and construction) and 
services (nursing care, insurances, hospital management, etc.) in relation to healthcare. We use the 
plural term “industries” rather than “industry” to emphasize the broad variety of sectors engaged in 
healthcare. Although health has become a fast-growing sector of global economies, the foundations of 
the welfare system, and one the major reasons for progress in the Human Development Index around 
the world during the twentieth century, very little is known about the conditions shaping the 
transformation of health industries from small, local, personal services into big, globalized, high-tech 
businesses. 
The heterogeneous nature of the health industries may account in part for the relative scarcity of 
related studies from a historical perspective. The World Health Organization, as well as the OECD 
official statistics about healthcare, tackle medical activities and measure human capital that includes 
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physicians, nurses, and pharmacists. Forbes and Fortune analyze medical and drug corporations, 
among them large manufacturers and distributors. National governments consider the wholesale and 
retail distribution of drugs and medical services via public and private institutions as entities that 
provide products and services related to healthcare. Health economics scholars concentrate the bulk 
of their research on studies financed and used by health insurance companies to analyze risk and 
health spending. In fact, the specialized literature reveals a clear divide. On the one hand are 
approaches from health economics, which tend to tackle current problems (such as growing costs, the 
organization of the health market, the role of insurance providers, and the financial impact of new 
technology) with little, if any, historical perspective. On the other hand, the approaches from the 
history of medicine and public health field focus more on social, cultural, and gender issues (such as 
the personal experiences of patients, the professionalization of nurses, social control through health 
policies, and the international expansion of Western medicine within the context of imperialism).  
The bibliometric analysis of the vast number of publications related to the history of health, history of 
hospitals, and history of medicine using the Web of Science, Scopus, and Mendeley, over the last 15 
years, below, reveals that the field has expanded enormously and is therefore difficult to summarize or 
analyze (see table 1). Pressure for academic productivity and the effects of the internet era in 
expanding the possibilities of cooperative research and publications may help explain the fact that 
there are more than one million references to the history of health, hospitals, and medicine alone.  
 
TABLE 1 HERE 
 
Works by health economists have helped shed light on the workings and challenges of current health 
systems. Nevertheless, they do not explain why or how medicine and health have transformed from 
local services into fast-growing and largely globalized businesses during the last century. What were 
the driving forces of transformation and growth in this sector? Which companies and entrepreneurs 
engaged in building new kinds of businesses to improve the population’s health and answer the needs 
of medical doctors and patients? What were their incentives, and what possible alternative choices 
and pathways were available to them during the modernization of the healthcare business of the 
twentieth century? How did a financial system take shape, operating on a foundation of insurance 
providers and state interventionism, to support the growth of the system? Answering such questions is 
essential to achieving a proper understanding of the historical development of health. Despite the 
sector’s tremendous record of development during the twentieth century, however, very few scholars 
have analyzed health from a systemic perspective adopting an approach of business and economic 
history.5 Numerous scholars have addressed the history of medicine and health, but they often opted 
for inquiries into specific, fragmented parts of the health market.  
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Hence, the objective of this special issue is to employ a longitudinal, business history-centric approach 
in analyzing and understanding the complex context in which the construction of health industries and 
services took place—via a variety of pathways—throughout the world since the 1900s. This volume 
first illustrates the role of path dependence and the diversity of the models that different countries 
followed in transforming locally embedded health services into fast-growing globalized businesses. 
Second, the articles in the special issue emphasize the impact of the diverse institutional frameworks 
that helped define national health systems. Third, the issue aims to shed new light on the emergence 
of new therapeutic agents and new frames of care and culture, as well as the influence of new actors 
and changing organizations. Fourth, the influence of entrepreneurship, together with different types of 
ownership and management styles, is a subject of analysis for both fostering a deeper understanding 
of the complexities in each country and exploring the branches of the health industry for establishing 
incentives, obstacles, and opportunities in the creation of technological and scientific innovations and 
the transfer thereof from firms to society. 
 
1. Literature review 
This volume builds on a rich and diversified literature in the history of medicine, pharmacy, and 
general science and technology pertaining to health. Numerous works have examined particular 
aspects of this transformation, but, unlike the articles in this issue, very few offer an inclusive 
perspective that establishes a dialogue with the diverse factors that have had and continue to have a 
key role in the construction of our national health systems: institutions, medical technology, and 
private and public healthcare companies.  
The most relevant literature can be classified in three major fields. First is the history of health system 
organization and funding.6 These works emphasize the evolution of public health systems and the 
funding structures of hospitals, addressing elements like the involvement of the state and insurance 
providers, the roles of local communities, the relative decline of philanthropy and charity in the 
Western world. These works, however, lack a focus on new medical technology and the action of 
private companies, which are vitally important in the diverse experiences of Japan, the United States, 
and some European areas like Catalonia and Madrid in Spain. Second, there are publications in the 
history of medical technology that have shed light on the process of innovation in health and medicine 
and demonstrated the role of social networks in the diffusion of new technology.7 However, these 
seldom embrace the analytical perspectives of business and economics and rarely account for the role 
of enterprises and market structures. Third, the pharmaceutical industry has generated several studies 
employing a business history approach.8 They follow a perspective that analyzes the competitiveness 
of firms relative to organizational capabilities, industrial organization, and markets. The existing 
research does not usually consider the organization of health systems and the interactions with other 
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actors within them (governments, insurance companies, and medical doctors) as determinants of 
change, though, and our special issue aims to contribute to the discussion on that point.  
Hence, there has been relatively little analysis of the construction and management of public and 
private hospitals and clinics, first of all, and the factors that created opportunities or obstacles for 
those entities in transferring modern, life-saving technologies and knowledge to real patients—to 
society. We also know relatively little about the construction of health insurance companies or the 
process through which, in some countries, periods of coexistence or private and public health 
insurance came about in order to finance the population’s access to scientific and technological 
modern healthcare innovations. Entrepreneurship and innovation among late comers in regions of the 
world that were far from the leading pioneers in Germany, France, the United Kingdom, the United 
States, Switzerland, and Japan, too, remain relative unknowns. How, when, and why did life-saving 
drugs or knowledge make their way to “the rest of the world?” In which subfields of the healthcare 
industries has “the rest of the world” innovated and transferred technological, scientific, and 
organizational developments into their public and private healthcare institutions? How can innovative 
entrepreneurs and small enterprises in the healthcare businesses grow and become medium or large 
corporations in markets increasingly dominated by oligopolies headquartered in a few pioneering 
countries? Through which possible mechanisms, in which context, and under which obstacles and 
incentives can these changes take place? We know extremely little about the history and typologies of 
historical regulatory systems affecting the volume and prices of drugs and medical services in our 
countries. Today, when so much is at stake, when we are witnessing the transitions and crises of 
national health systems created in the latter half of the twentieth century, we believe that business 
historians have a responsibility to integrate dispersed, isolated methodologies and approaches into a 
historical overview of the historical construction of our national health systems.  
Given the scope of that goal, this special issue cannot fully cover all the aspects of the institutional and 
business dimensions of health systems. This introduction concentrates on a few relevant topics: 
medical professions, innovation and new medical technologies, and the creation, management, and 
growth mechanisms of healthcare firms and corporations. It then provides a general model for 
historical analysis of the construction and development of health systems around the world. 
 
2. Medical professions 
Since ancient times, Greek, Roman, Chinese, Arab, South American, and African practitioners created 
and preserved knowledge about remedies and techniques to prevent illnesses, safeguard against 
epidemics, and heal and treat the sick with varying degrees of centralized control and funding. The 
commercial revolution of the fifteenth century onward brought unprecedented changes in political 
systems across the world, along with wars and upheavals both social and demographic, all of which 
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had consequences on the world’s diverse healthcare institutions. Asia and the Middle East maintained 
ancient systems of religious provision of care for the poor and sick in large, centralized buildings and 
temples where religion and local healing traditions prevailed. Meanwhile, the Western world 
witnessed a more dramatic change from the Middle Ages and well into the sixteenth and seventeenth 
centuries—a long period of darkness during which authorities disregarded and abandoned advanced 
Greek, Roman, and Arab medical knowledge and institutions and yielded control of public healthcare 
to religious authorities and charitable institutions. According to those in control, illness was a 
consequence of sin, as was the study of the human body. The sixteenth-century Protestant revolution 
and seventeenth-century scientific revolution were transformations that elevated the medical 
profession to a higher social status in some Western European countries, as the anatomic analysis of 
the body was no longer a condemned pursuit and the regulation of scientific studies started to take 
shape. The biological study of plants and the exploration of medical drugs of organic origin, which had 
started in a scattered, informal way as curious individuals from a variety of professional origins in 
other parts of the world delved into inquiry, received a more institutionalized form of 
acknowledgment in the eighteenth century in most of the Western world; royal institutes, royal 
associations, and specialized books and journals lent that brand of research more legitimacy.9 
“Imperial science” during the nineteenth century contributed to marginalizing ancient medical 
knowledge from non-Western civilizations and also spreading to and imposing on distant parts of the 
world Western academic knowledge and medical institutions and practices relating to biology, 
chemistry, and medicine thanks to new rotary printing machinery, continuous paper production, new 
mass media, and, of course, the revolutions in communication and transportation stemming from the 
first wave of globalization.10 Since the mid-nineteenth century, until the end of the two World Wars, 
most countries in the Western world had established new, centralized national sanitary legislation and 
governmental agencies that slowly took control of the business of health away from religious, 
philanthropic, or local institutions. Closely linked to the new role of governments in taking control of 
health problems, particularly epidemics (many related to the processes of mass migration and 
industrialization of the world), countries set up new national educational institutions and plans to train 
members of the medical profession—now in urgent demand—through new faculties and schools of 
medicine, pharmacy, biology, and chemistry. The number of graduates of medicine, pharmacy, and 
chemistry programs increased in the last decades of the nineteenth century, as records of existing 
student registers at European universities and the preserved records of local and provincial doctors’ 
associations reveal.11 
International statistics that take account of the expansion of the medical profession and the 
construction of Western-style hospitals started to emerge after World War I in a fragmented, 
experimental way. The figures that came from numerous European, American, Asian, and African 
countries have only recently came under scholarly scrutiny, with researchers examining the pioneering 
efforts at transferring knowledge of the modern organization of large hospitals.12 Statistical collection 
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only became a systematic, significant process after the creation of international associations focusing 
on healthcare after World War II. The World Health Organization and OECD provide relatively reliable 
and representative information for a large sample of countries since the 1960s and particularly after 
the 1990s. As the OECD statistics in Tables 2, 3, and 4 illustrate below, only a handful of countries with 
high concentrations of professionals— Germany, the United States, Japan, Spain, Italy, and the United 
Kingdom—have substantial amounts of data before the crisis in the 1970s. These professionals were 
physicians, nurses, and pharmacists. Considering the numbers of professionals per 1,000 inhabitants, 
nurses have clearly been the segment most available to the sick.  
 
TABLE 2 HERE 
TABLE 3 HERE 
TABLE 4 HERE 
 
3. Innovation and the history of new medical technologies 
The various works on the history of the organization and funding of hospitals emphasize that the 
introduction of modern management practices from the private sector and the diversification of 
financial resources were key conditions for enabling the growth of the sector during the twentieth 
century. Yet, organizational scholars very rarely analyze the reasons and the necessity to develop and 
grow. In brief, the literature on the subject does not tackle the issue of change in external conditions, 
the new social and political demand for health services in liberal societies and traditional developing 
countries with accelerated urbanization and immigration, or the pressure to develop medical 
innovations to meet the new challenges.  
Studies of the history and sociology of medical technology can thus help us better understand the 
conditions of innovation in medicine and their relations with the healthcare system. In this field, the 
influence of social constructivism was very important. In the wake of groundbreaking books by Bruno 
Latour and Steve Woolgar,13 as well as Thomas Hugues, Wiebe Bijker, and Trevor Pinch,14 many 
authors tackled cases of medical innovation from a social history perspective. Stuart Blume studied the 
example of medical imagery,15 while Thomas Schlich focused on surgery,16 and Julie Anderson, Francis 
Neary, and John V. Pickstone analyzed hip replacement technology.17 All these works made the 
argument that medical innovation was not a “natural” phenomenon. They highlighted the major roles 
of social networks in bringing an innovation into the public eye—on a global scale—and professional 
use. In this sense, medical innovation can be approached as a social construction: what innovation 
literature has labeled as innovation through “communities of knowledge” or what entrepreneurial 
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scholars have described as “collective entrepreneurship.”18The articles in this special issue are 
especially important in contributing new empirical evidence about the complex social, political, and 
educational professional contexts in which medical innovative knowledge and management can and 
must develop. 
However, the sociology and social history of medical technology has usually overlooked the 
establishment of connections with business and the relevant economic context, a trend that this 
special issue aims to change. Analyses of innovation in medicine must address the pertinent 
relationships with hospital finances, the effects of market regulation, and the roles of health insurance. 
As in other economic sectors, innovation in medical technology occurs within organizations 
(universities, R&D centers, and enterprises) within a given market; therefore, business conditions have 
a major impact on the way medical innovation comes about. The pharmaceutical and drug industry 
appears here as a specific case, as pharmaceuticals represent one of the very few medical technologies 
to have been the subject of special analysis by business historians. Most of the works focus, however, 
on the first phase of drug innovation, running from the development of aspirin in the early twentieth 
century to that of beta-blockers in the 1960s. Innovation in the drug businesses followed different 
waves, of course, aligning closely with the product life-cycle theory. The development of cell 
biochemistry in the 1970s and insights into molecular structure since 2000 have led to the emergence 
of new players, mostly start-ups, which followed various paths of development (transformation into 
global companies, absorption by established multinational enterprise, and decline, for instance). The 
dynamics of the drug industry since the 1970s are still under-addressed by scholars, while they have a 
growing impact on healthcare consumption.  
  
4. The creation, management, and financing of Healthcare corporations and organizations  
Hospitals, manufacturers of medical technologies and drugs, and wholesale and retail distributors of 
technologies and drugs are the main players in the business of healthcare industries and services. 
Large hospitals were well-known since antiquity in the Middle East; there have also been large 
charitable hospitals in the Western world since the fifteenth century, mostly in the largest urban 
centers of Europe and the Americas. Large hospitals, in their modern form, began emerging slowly in 
the late nineteenth century and then in an accelerated way in the mid-twentieth century. In ancient 
and early medieval times, hospitals were often financed by charitable religious organizations, local 
institutions, and pious sponsors, with non-professional voluntary entities with little or no professional 
medical or administrative knowledge responsible for hospital management in nearly all cases. The 
primary objective of these hospitals centered on taking care of and controlling the poor and marginal 
sectors of society. Their original goal was, in many cases, to take away sick poor people and their 
illnesses (or deaths) from the eyes of society at large. It was industrialization and the rapid 
urbanization of the Western world first—and the rest of the world shortly thereafter—that increased 
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the speed in the growth of the poor and sick populations, transforming what was once a charitable 
action into an urgent social problem of public healthcare; that transformation gradually prompted 
local and national authorities to realize the need to organize and control the situation, which after the 
nineteenth century became a problem of civil order, in a more centralized, civil way relative to the 
former administrations of religious institutions and specific individuals. It was impossible for the 
church or for pious individuals to finance and manage enough buildings to accommodate the millions 
of people migrating from the countryside into the industrialized cities of Europe or the East-Coast 
cities of the United States after the mid-nineteenth century. It was also a problem for large 
commercial cities in the East, like Hong Kong, to deal with the massive waves of migration they 
witnessed in the nineteenth century, which brought with them epidemics and illnesses. During the late 
nineteenth century, the effects of expanding Latin American metropolises, the construction of the 
Panama Canal, and the Spanish-American Wars of the late nineteenth century revealed how inefficient 
traditional hospitals for the poor were in treating and healing an ballooning number of wounded and 
sick people as the imperial powers and foreign multinationals—together with the urban pull from the 
countryside—drove millions to large cities in the region.19 From the mid-nineteenth century onward, 
the world’s large cities, industrialized countries, and urban centers where the economic powers dealt 
in trade and logistics reformed or created brand-new, larger centralized hospitals. Mechanisms 
combining public money and private funding also established themselves as the key most efficient 
approaches on a global scale. The medical and managerial organization of new large hospitals and the 
underlying philosophical and political basis of the societies and institutions in which the hospitals 
operated varied greatly in Asia, Western and Eastern Europe, North and South America, and Africa and 
Australia. Despite that variety, facilities expanded across the board, and a transnational process for 
disseminating organizational and medical ideas took place well before World War II, with the exchange 
and movement of technologies, human capital, funds, and ideas picking up speed right after the 
1940s.20 
Hospitals had to be built, organized, and managed by administrative staff accountable for the funds 
supplied by the authorities provided with hospital equipment, supplied with drugs, and connected to 
the regular-salaried services of the new class of professionals in medicine and the pharmacy that was 
graduating by the thousands at the end of the nineteenth century from European and North American 
universities.  
Most of the works on the historical evolution of management and finances of hospitals have tackled 
American and British cases, although there is ongoing research on digitalized account books and 
commemorative books with historical accounts and data on hospital organizations at the hospitals of 
France, Germany, Spain, Italy, Hong Kong, China, Egypt, Colombia, Argentina, Mexico, Peru, Brazil, 




In the United States, there were strong pressures seeking the modification and modernization of the 
country’s fragmented, poor hospital system in the second half of the nineteenth century. With the 
deaths of legions of soldiers in the American Civil War, the casualties of the Spanish-American Wars in 
Cuba and the Philippines in the late nineteenth century, and the rapid immigration and urbanization 
on the East and West Coasts since those years, the unprecedented problem of managing the wounded 
and addressing epidemics affected the country both at home and abroad in its international 
operations. The pressure led to an organizational and managerial revolution in US hospitals that 
science and business historians have only superficially tackled thus far. New research reveals that 
there were two driving actors in the modernization of American hospitals in this context of change 
from the demand side during the late nineteenth century and the first half of the twentieth century: 
the Army and the Navy, on the one hand, and the influence of industrial ideas from Taylorism and 
Fordism in hospital management.22 The wars made the medical services of the US Army and Navy 
realize the poor conditions in which thousands of their wounded soldiers received medical attention at 
home and abroad, first of all. In addition, the wars exposed the urgency of not only improving the 
endowment of medical products and professionals for the soldiers but also organizing new, large, 
centralized buildings, managed with new logistics to move provisions more efficiently and 
standardized medical resources from one place to another, to save more lives and improve the 
psychological and physical conditions of the sick and wounded at hospitals. In parallel to the new 
hospitals organized by the US Army and Navy, new hospitals in East- and West-Coast metropolises 
were built, or old ones were moved to new locations with expanded facilities. Scale and scope in the 
new hospitals were chief concerns, and the owners of the new hospitals embraced the new industrial 
organizational ideas of the new large corporations from the start in hopes of organizing or reorganizing 
hospital resources and designs and also managing the facilities.23 One must stress the influence of 
Alfred D. Chandler, to whom several historians of medicine explicitly have referred, on the literature 
about the subject. For example, Neil Larry Shumsky argued as early as 1978 that “the world of 
contemporary medicine is one of structure, bureaucracy, and organization”24 and explained the 
development of the municipal clinic of San Francisco based on Chandler’s work on large enterprises. 
Barbara Bridgman Perkins, meanwhile, asserted that American hospitals reorganized during the years 
1900–1930 through the introduction of management methods from the industrial sector (essentially 
division of work and hierarchy), which gave way to the establishment of medical specialties.25 
However, the most influential work in this field is undoubtedly Joel Howell’s seminal book on New 
York Hospital and Pennsylvania Hospital.26 Based on a study of patient files from the two hospitals 
between 1900 and 1925, he showed how medical technology, such as X-ray equipment and 
laboratories, became central to hospital administration. Howell’s primary contribution lay in 
demonstrating that the development of hospitals relied as much on organizational and managerial 
issues than on medical innovation itself. According to sociologists Marc Berg and Stefan Timmermans, 
the standardization of hospital infrastructure during the beginning of the twentieth century in the 
United States was the first step of a general trend that reached the entirety of medical practice during 
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the 1980s and 1990s, characterized by the generalization of a so-called “evidence-based medicine” 
that relies on international standardized norms.27 
Some other scholars focused on the issue of financing hospitals, and more broadly health systems, 
from a historical perspective. Here, too, the most important works came from Anglo-Saxon countries. 
Steven Cherry published extensively on the evolution of hospital funding in the United Kingdom, 
stressing the shift from philanthropy to other sources (public funding, patients, and insurance 
providers).28 In the US, one can cite the research of Stephen Kunitz on the emergence of health 
insurance in the early twentieth century,29 and, more recently, of Christy Chapin on the development 
of insurance to the present day.30 As financing health and medicine had become a major political issue 
throughout Western countries in the 1990s, many scholars undertook historical studies on the 
historical development of funding for health in countries, such as Germany,31 Spain,32 France,33 and 
Switzerland.34 
Hospitals had to have sufficient supplies of medico-technical equipment and drugs, the latter of which 
also served outpatients. During the end of the nineteenth century and the first six decades of the 
twentieth century, new firms and corporations appeared, first in developed pioneering countries, and 
eventually in other latecomer countries, to fill the expanding needs for new products: drugs, medical 
machinery, medical technology, and precision devices. In the pharmaceutical and chemical industries, 
the pioneering firms first established new scientific and technological knowledge and learning bases 
between the 1870s and the 1930s; after World War II and through the 1990s, the pioneers then 
established solid entry barriers to fend off competitors at home—and particularly abroad—in the 
markets they were creating with disruptive new products and services. Only from the end of the 1990s 
onward did global competition from challengers begin to erode the competitive basis of some of the 
industry’s first comers.35 This chronology explains well the establishment of leaders like Bayer, Ciba 
Geigy, and Sandoz in the United States, Germany, France, the United Kingdom, Switzerland, and Japan. 
In latecomer countries, many of these innovative products and services arrived soon due to early 
nineteenth-century contact between scientists and the leading pioneering centers and corporations, as 
well as via the efficient networks that faculties of medicine and pharmacy in Europe, America, and Asia 
had established among them to communicate knowledge of innovations quickly and efficiently. 
Regarding the manufacture and distribution of hospital equipment, in Europe, North America, Latin 
America, and Asia, small and medium companies with scientist-entrepreneurs soon started to register 
their mercantile activity in order to take advantage of the expanding market opportunities as millions 
of sick patients congregated in the industrialized cities that began to grow in tandem with 
industrialization and globalization after the mid-nineteenth century. Studies on trademarks and 
corporate monographs have revealed the coexistence of multiple pathways of this multiplication of 
small entrepreneurship in the production of chemical drugs and medicines that appeared in the mid- 
and late nineteenth century. Some grew serving the military needs of their armies (Nobel in Russia, 
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Behring in Germany, Abbott and Baxter in the United States); some transformed into large 
multinationals in the food industry in the twentieth century (like Nestlé, Danone, and Coca Cola); some 
developed via government support to cover large population needs (CSL in Australia); some changed 
headquarters due to war pressures and enjoyed successes in becoming large multinationals on other 
continents (Danone moved from Spain to France, for example, while Andrómaco shifted from Spain to 
the United States and then to Central and Latin America). Of the litany of small laboratories that 
existed before the 1920s, however, very few remained intact after the 1950s; many did not survive the 
two World Wars and the collapse of global trade in the interwar period.36 
After World War II, there was a decline in the number of small and medium family-owned companies 
in Western Europe, particularly in the United Kingdom, and a concentration of the chemical and 
pharmaceutical and medical drugs business into larger corporations.37 North American corporations 
were particularly well placed to assume leadership in the new world order, including in the healthcare 
industries covering the manufacturing and distribution of hospital equipment and drugs. As the need 
for complex technologies and medical drugs expanded with population growth in the postwar period, 
and as hospitals grew in number to serve the increasing number of potential sick people, hospitals 
faced the need to purchase diagnostic instruments, pharmaceuticals, and laboratory equipment like 
sterilizers, masks, gloves, microscopes. During the late nineteenth century in the US, as was the case in 
Europe, there were many small manufacturers of such items; the Gendron Wheel Chair Company 
(founded in 1872), Davol Rubger Company (1874), American Sterilizer Company (1894), Beckton, 
Dickinson and Company (1897), and Bard-Parker Company Inc. (1915) are several examples. In the 
pharmaceutical industry, Merck and Company, Abbott Laboratories, Cutter Laboratories, and Mead 
Johnson and Company were all founded between 1883 and 1900. However, most manufacturers had 
to sell their products directly to thousands of hospitals across the country, and the transaction costs 
involved were high. The American Surgical Trade Association, founded in 1902, had attempted in vain 
to organize the industry. Then, a talented medical supplies salesman named Foster McGaw emerged 
and, in 1921, founded the American Hospital Supply Corporation—which would go on to be one of the 
world’s largest wholesale distributors of hospital supplies through 1985.38 The reasons behind their 
success were the new competencies developed in connecting distant manufacturers, establishing price 
convergence across distant hospitals within the given country and abroad, and organizing of a 
professional salesforce trained specifically for the products that they had to sell. This “Chandlerian” 
corporation would be difficult to imitate in other countries until the late 1980s. In Western Europe, 
particularly in Germany and German-speaking countries, the same type of concentration took place in 
a different context. Around twenty local manufacturers and distributors were taken over during World 
War I by the X-ray equipment producer Reiniger, Gebbert & Schall, a company that was based in 
Erlangen and founded in 1887. In 1921, a holding company called Industrie-unternehmungen AG 
(INAG) took control of the group to provide all the technical equipment that hospitals and 
independent doctors needed. A few years later, in 1924, Siemens & Halske purchased INAG and 
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established itself as a leader in hospital equipment business.39 This leadership grew even stronger and 
extended to emerging countries after WWII, when Siemens engaged in hospital building.40 
OECD statistics again prove useful in understanding the dynamics of hospital systems and healthcare 
business in various countries over the last thirty years (see Tables 5 and 6 below). The availability of 
beds per hospital is a simple variable that indicates the concentration of professionals, drugs, and 
services that have implemented healthcare among populations across countries; the figures 
demonstrate the United States’ dominance in total number of hospital beds, followed by Japan and 
Germany. When one considers the number of hospital beds per 1,000 population in each country, the 
power of the United States becomes less pronounced, and Japan appears as the best-served country in 
that different statistical context. Moreover, the numbers express the existence of a broad variety of 
systems (the high density of small hospitals in Japan vs. the presence of a small group of large hospitals 
in Western Europe) with a major impact on the diffusion of medical technology and the consumption 
of healthcare. 
TABLE 5 HERE 
TABLE 6 HERE 
 
5. For a business history of health 
The literature on the management of hospitals and the social history of medical technology offers an 
important basis for building and developing a new approach to considering the transformation of 
health into a fast-growing business during the twentieth century. A business history of health requires 
a systemic perspective that includes the producers (companies), practitioners (medical doctors), and 
users (patients and hospitals) of medical technology, as well as the providers of capital and the bodies 
responsible for regulating the health system (government). Figure 2 illustrates the organization of a 
healthcare system.  
Business historians can employ this model as an analytical tool for discussing the development of 
health in various countries through different examples and sources. Of course, it is not always possible 
to consider all five actors with the same importance in any case study. Some scholars may give more 
attention to relations between two of the actors (insurance providers and government, practitioners 
and patients, or technology producers and investors, for example). They should, however, be aware of 
the existence of and roles played by other actors in the health system to provide a comprehensive 
view of the business history of health. 
 




The articles in this special issue focus particularly on one or two of these actors but explain the 
interactions with other actors to offer a fuller understanding of how given health systems developed, 
either nationally or globally. The perspective of the producers of medical technology is the framework 
for the three first articles, which analyze various cases of development and growth of small and 
medium enterprises in a sector dominated by large, multinational enterprises. Paloma Fernández 
Pérez, Nuria Puig, Esteban García-Canal, and Mauro F. Guillén demonstrate that the successful 
internationalization of small and medium enterprises in a developing economy (the plasma laboratory 
Grifols and the pharmaceutical company Ferrer, both from Spain) relied not only on the internalization 
and transfer of knowledge from US and German first movers but also on the local institutional 
environment, a system of innovation that encouraged the collaboration of scientists, politicians, and 
entrepreneurs in modernizing and transforming local healthcare businesses. The Barcelona district of 
biomedical scientists gave the entrepreneurs the opportunity to build the learning bases necessary for 
launching cooperative efforts with large foreign companies. For example, the roots of Grifols go back 
to a small clinical laboratory that doctors from the University of Barcelona’s Faculty of Medicine 
opened in 1910. During the following decades, members of the Grifols family studied medicine and 
pharmacy and acquired scientific knowledge from both Germany and the US after World War II. The 
subsequent expansion of these family firms in Europe, the US, and Japan resulted from cross-border 
mergers and acquisitions that allowed them to acquire knowledge and develop their R&D facilities.  
The article by Ken Sakai on Mani, a Japanese surgical needle manufacturer, during the second part of 
the twentieth century is another example of how a small company in a country with a seemingly weak, 
uncompetitive pharmaceutical industry managed to grow. Mani’s technological development was 
achieved through cooperation with large private companies, like Toshiba, and semi-governmental 
organizations such as the Atomic Energy Research Institute. Moreover, the company’s growth tied into 
a fast-expanding hospital market, then the company started to expand abroad since the 1990s, when 
the number of hospitals in Japan started to stagnate then to decline. This example thus reflects the 
impact of regulation in the healthcare market on medical technology firms: the lack of interventionism 
on the part of the Japanese government, which led to the opening of numerous hospital beds (about 
700,000 in 1960 and more than 1.6 million in 1990), represented an opportunity for many small 
companies like Mani because it offered a large market for medical devices. 
The third paper on medical technology firms, by Maki Umemura, compares firms in regenerative 
medicine since the 1970s in the US, UK, and Japan. She argues that this specific sector was shaped by 
more than just technological issues related to cell-based therapies, regardless of how undoubtedly 
complex the issues may be. She details the relations between scientist-entrepreneurs and investors, 
the latter of which were impatient to transform firms into highly profitable businesses and sometimes 
withdrew their investments. The connection between capital and medical technology shines through 
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in Umemura’s incisive analysis. Another dimension that comes to light through the paper’s 
international comparison is the importance of regulation. R&D and the consumption of biotechnology 
products are subject to legal frameworks that differ between countries—and that regulatory 
environment has a deep impact on innovation. 
Next, three articles analyze the perspectives of the organization and regulation of healthcare markets. 
Sabine Schleiermarcher focuses on the attempts of the Allied forces in Germany to restore medical 
care and public health service immediately after World War II. She also looks at how, in the context of 
the European Recovery Program, the Rockefeller Foundation organized grants, visitation programs, 
and a school of public health. The article shows how the North American initiative underestimated the 
strength and endurance of pre-World War II traditions of public health organization and also 
miscalculated the medical profession’s resistance to adapting outside models of medical care and 
service. 
The article by Jean-Paul Domin tackles state interventionism in France between 1890 and 1938, an 
effort to implement a public insurance system that would support the access of the population to 
healthcare—what the author calls the “socialization of healthcare demand.” The interventionism 
relied both on assistance (free medical assistance for the poor, introduced in 1893) and insurance 
(workers’ health costs due to work accidents, covered by employers in 1898, and social insurance for 
all citizens, enacted in 1928–1930). Regulated competition following state interventionism led medical 
professions to organize themselves and adopt common fees for government-supported patients, as 
free competition would result in decreasing revenues. The important outcomes of this policy were 
increasing insurance coverage (from less than 5% of the population in the late nineteenth century to 
46% after 1930) and rapid development of the hospital market—due to growing guarantees of 
revenues by patients. The state organized the competition, but the business management of medical 
doctors and hospitals was autonomous. 
Roser Álvarez studies the important changes that took place in the Chinese public healthcare system 
during the Maoist period (1949–1976), confirming the general increase in health resources in those 
years. The study also reveals a decrease in infectious diseases, a reduction in mortality rates, and an 
increase in life expectancy. However, she also uses provincial data for the Henan Province to uncover a 
strong provincial inequality in the allocation of health resources, an imbalance that may have 
accounted for the gaps in the provincial and regional health indicators she presents. Her study 
illustrates the transformation and endurance of traditional healthcare services like the rural medical 
agents that took shape in years and regions where large hospitals could not be built. 
The users of medical technology are the main subject of the article by Pierre-Yves Donzé, who tackles a 
case study of the transnational experiences of knowledge transfer from the West to the East: the 
introduction of Western hospital designs to Japan between 1918 and 1970. The paper demonstrates 
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the influence and relevance of studying hospital design and architecture. Neither factor is a simple, 
short-term decision with minimal significance; after all, hospitals are enduring service infrastructures 
that, on average around the world, serve millions of people over periods lasting more than a century. 
Making the right decision on an efficient design that accounts for the needs of the population, the 
costs involved in maintenance and repairs, and the human capital that must coexist and manage the 
hospital efficiently is of paramount importance—yet historians of medicine and business have tended 
to overlook the topic. Donzé describes the transformation in Japan from prewar models of small 
hospitals in urban areas to the large public hospitals of the post-war era, explaining how the main 
drivers of the new hospitals were architects with knowledge of large Western hospitals who had the 
support of local authorities to introduce foreign designs in dealing with new local needs. The article 
details some of the pioneering new Japanese hospitals, the architects behind them, and the context 
that helps elucidate the introduction and hybridization of Western concepts of hospital design in 
Japan. 
Finally, this special issue includes an article by Jerònia Pons and Margarita Vilar on private providers of 
capital for healthcare in Spain during the last century: private health insurance companies. The authors 
assert that the private insurer community is not a new outcome of the current welfare crisis in Europe 
but rather an old actor that has been part of the healthcare system for a century, flexibly adapting to 
changing external institutional and economic conditions. Private insurance companies have 
transformed not only their internal organizations and strategies but also their external relationships 
with foreign competitors and the state. 
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